ALLR Allarity Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ALLR

Price (delayed)

$1.7

Market cap

$27.05M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.72

Enterprise value

$18.73M

?
Relative Growth: Rel. Growth: 20
Relative Strength: Rel. Strength: 83
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 35
Highlights
Allarity Therapeutics's EPS has surged by 56% YoY and by 8% QoQ
Allarity Therapeutics's net income has surged by 52% YoY
ALLR's equity has plunged by 63% YoY and by 30% from the previous quarter
Allarity Therapeutics's quick ratio has shrunk by 58% YoY and by 39% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ALLR

ALLR stock price

How has the Allarity Therapeutics stock price performed over time
Intraday
7.59%
1 week
1.8%
1 month
36%
1 year
95.4%
YTD
57.41%
QTD
55.96%

Financial performance

How have Allarity Therapeutics's revenue and profit performed over time
Revenue
$345,000
Gross profit
$345,000
Operating income
-$12.26M
Net income
-$11.25M
Gross margin
100%
Net margin
-3,260.6%
ALLR's operating income has surged by 53% year-on-year and by 2.8% since the previous quarter
Allarity Therapeutics's net income has surged by 52% YoY
Allarity Therapeutics's operating margin has increased by 10% from the previous quarter
The gross profit has grown by 8% from the previous quarter

Price vs fundamentals

How does ALLR's price correlate with its fundamentals

Growth

What is Allarity Therapeutics's growth rate over time

Valuation

What is Allarity Therapeutics stock price valuation
P/E
N/A
P/B
3.89
P/S
78.69
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
54.3
Allarity Therapeutics's EPS has surged by 56% YoY and by 8% QoQ
ALLR's P/B is 90% above its last 4 quarters average of 1.9
ALLR's equity has plunged by 63% YoY and by 30% from the previous quarter
ALLR's revenue is up by 8% since the previous quarter

Efficiency

How efficient is Allarity Therapeutics business performance
Allarity Therapeutics's ROA has increased by 49% YoY and by 5% from the previous quarter
ALLR's ROE is down by 29% QoQ but it is up by 28% YoY
Allarity Therapeutics's return on sales has increased by 9% QoQ

Dividends

What is ALLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALLR.

Financial health

How did Allarity Therapeutics financials performed over time
ALLR's total assets is 25% more than its total liabilities
Allarity Therapeutics's total liabilities has soared by 153% YoY
ALLR's total assets has soared by 91% from the previous quarter and by 17% YoY
ALLR's equity has plunged by 63% YoY and by 30% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.